This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Miacalcic 200 IU Nasal Spray Solution - withdrawn throughout the European Union

2014-12-17 14:59:31 (11 year(s) ago)

Summary

(Novartis Pharmaceuticals UK) Increased risk of malignancies with long -term use of calcitonin – class 2 action within 48 hours. (EL 13(A)11)

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!